NAC reversed CSE-induced Gefitinib resistance in PC-9 and A549 cells (P<0.05).<h4>Conclusions</h4>The ROS/Sirt3/SOD2 pathway is involved in CS-induced Gefitinib resistance in NSCLC. The gene discussed is SIRT3; the disease is non-small cell lung carcinoma.